ProKidney Stock Discussion

$ProKidney (PROK.US)$ anytime soon. I know someone following it.

$ProKidney (PROK.US)$
ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting
Positive
FDA confirmation that PROACT 1 Phase 3 study could be sufficient for full regulatory approval
Accelerated approval pathway available with eGFR slope as surrogate endpoint
Strong cash position of $406.8 million, supporting operations into 2027
Reduced R&D expenses by $0.9 million year-over-year
Slight improvement...

$ProKidney (PROK.US)$ ProKidney | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Aaron Cowen(10.47%),Suvretta Capital Management, LLC(9.8%), etc.
SEC· 11 mins ago

$ProKidney (PROK.US)$ Today announced that the Company will present five posters, including one late-breaking clinical trial, at the upcoming American Society of Nephrology's (ASN) Kidney Week being held on October 23-27, 2024, in San Diego, CA.

$ProKidney (PROK.US)$ Reuters· 2 mins ago
ProKidney Announces Strategic Updates to Its Phase 3 Program to Accelerate Rilparencel’s Registrational Path to Potential Approval in the U.S.   Believes Phase 3 Regen-016 (Proact 2) Trial Is Not Required for Initial U.S. Registration

$ProKidney (PROK.US)$ ProKidney Announces the Closing of $140 Million Public Offering of Class a Ordinary Shares and Concurrent Registered Direct Offering, Including Exercise of Underwriters’ Option

$ProKidney (PROK.US)$ Made a nice recovery from that upsized offering